News/ News/ Oncology Exact Sciences buys cancer detection company Thrive for $2.15 billion Catherine Longworth cancer, diagnostics, Exact Sciences, liquid biopsy, M&A, Thrive 0 Comment Stocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK Share X Exact Sciences buys cancer detection company Thrive for $2.15 billion https://pharmaphorum.com/news/exact-sciences-buys-early-cancer-detection-company-thrive-for-2-15-billion/
cancer, diagnostics, Exact Sciences, liquid biopsy, M&A, Thrive
0 Comment
